Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients

NCT07673861 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Royal Marsden NHS Foundation Trust